<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01272063</url>
  </required_header>
  <id_info>
    <org_study_id>HD-OCT-DR-2010-1</org_study_id>
    <nct_id>NCT01272063</nct_id>
  </id_info>
  <brief_title>Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography</brief_title>
  <official_title>Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carl Zeiss Meditec, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DataMed Devices Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Carl Zeiss Meditec, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the areas designated as elevated retinal pigment
      epithelium (RPE) by the Cirrus HD-OCT versus those designated as drusen on color fundus
      photographs (CFPs).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multiple site study. Ocular history and examination will be conducted
      on consented subjects to determine further participation in the study. Subjects qualified to
      continue will undergo color fundus photography and imaging of their study eye using the
      Cirrus HD-OCT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To compare area measurements of elevated RPE as observed in the Cirrus HD-OCT versus those designated as drusen on color fundus photographs.</measure>
    <time_frame>Study was released before December 1, 2012</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To describe the clinical factors that affected the automated segmentation of elevated RPE by the Cirrus HD-OCT.</measure>
    <time_frame>Study was released before December 1, 2012</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>To describe the qualitative similarities and differences between the areas designated as elevated RPE by the Cirrus HD-OCT versus those designated as drusen on color fundus photographs.</measure>
    <time_frame>Study was released before December 1, 2012</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">91</enrollment>
  <condition>Drusen Stage Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Dry AMD with macular drusen</arm_group_label>
    <description>Patients diagnosed with dry AMD with macular drusen</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary Care Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females 50 years of age or older diagnosed to have dry AMD with macular
             drusen.

          -  Drusen should not be combined with other lesions such as geographic atrophy (GA) or
             choroidal neovascularization.

          -  Able and willing to make the required study visits.

          -  Able and willing to give consent and follow study instructions.

        Exclusion Criteria:

          -  History of retinal surgery, laser photocoagulation, and/or radiation therapy to the
             eye.

          -  Evidence of other retinal diseases of the eye, including wet AMD, diabetic
             retinopathy, diabetic macular edema, or significant vitreomacular traction upon
             dilated examination, or upon evaluation of retinal photos.

          -  Thick media opacity or inability to fixate that precludes obtaining acceptable scans.

          -  Concomitant use of hydrochloroquine and chloroquine.

          -  Unable to make the required study visits.

          -  Unable to give consent or follow study instructions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Rosenfeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bascom Palmer Eye Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carmelina Gordon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TLC Eyecare and Laser Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eugene Lit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>East Bay Retina Consultants</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brandon Lujan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Coast Retina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>East Bay Retina</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Coast Retina</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94107-1756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bascom Palmer Eye Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TLC Eyecare and Laser Centers</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, Pankow JS, Klein BE. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010 Jun;128(6):750-8. doi: 10.1001/archophthalmol.2010.92.</citation>
    <PMID>20547953</PMID>
  </reference>
  <reference>
    <citation>Varma R, Azen SP, McKean-Cowdin R, Paz SH, Torres M, Barrera J, Choudhury F, Cisneros L, Chung J, Corona E, Cuestas C, Dzekov J, Foong AW, Lastra C, Lai MY, Martinez G, Shtir C, Smith RE, Tetrow L, Wang Y, Wu J, John L, Tucker K, Klein R, Meuer SE, Knutson MD, Neider M. Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol 2010; 149(5):741-51.</citation>
  </reference>
  <reference>
    <citation>Yi K, Mujat M, Park BH, Sun W, Miller JW, Seddon JM, Young LH, de Boer JF, Chen TC. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration. Br J Ophthalmol. 2009 Feb;93(2):176-81. doi: 10.1136/bjo.2008.137356. Epub 2008 Aug 12.</citation>
    <PMID>18697811</PMID>
  </reference>
  <reference>
    <citation>Jain N, Farsiu S, Khanifar AA, Bearelly S, Smith RT, Izatt JA, Toth CA. Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4875-83. doi: 10.1167/iovs.09-4962. Epub 2010 Apr 14.</citation>
    <PMID>20393117</PMID>
  </reference>
  <reference>
    <citation>Stopa M, Bower BA, Davies E, Izatt JA, Toth CA. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina. 2008 Feb;28(2):298-308. doi: 10.1097/IAE.0b013e3181567798. Erratum in: Retina. 2011 Jun;31(6):1236.</citation>
    <PMID>18301035</PMID>
  </reference>
  <reference>
    <citation>Ahlers C, Götzinger E, Pircher M, Golbaz I, Prager F, Schütze C, Baumann B, Hitzenberger CK, Schmidt-Erfurth U. Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2149-57. doi: 10.1167/iovs.09-3817. Epub 2009 Sep 24.</citation>
    <PMID>19797228</PMID>
  </reference>
  <reference>
    <citation>Friberg TR, Huang L, Palaiou M, Bremer R. Computerized detection and measurement of drusen in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):126-34.</citation>
    <PMID>17396693</PMID>
  </reference>
  <reference>
    <citation>Munch IC, Ek J, Kessel L, Sander B, Almind GJ, Brøndum-Nielsen K, Linneberg A, Larsen M. Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. Invest Ophthalmol Vis Sci. 2010 May;51(5):2317-21. doi: 10.1167/iovs.09-4482. Epub 2009 Dec 10.</citation>
    <PMID>20007824</PMID>
  </reference>
  <reference>
    <citation>Wojtkowski M, Sikorski BL, Gorczynska I, Gora M, Szkulmowski M, Bukowska D, Kaluzny J, Fujimoto JG, Kowalczyk A. Comparison of reflectivity maps and outer retinal topography in retinal disease by 3-D Fourier domain optical coherence tomography. Opt Express. 2009 Mar 2;17(5):4189-207.</citation>
    <PMID>19259255</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2011</study_first_submitted>
  <study_first_submitted_qc>January 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2011</study_first_posted>
  <last_update_submitted>June 24, 2013</last_update_submitted>
  <last_update_submitted_qc>June 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drusen</keyword>
  <keyword>Dry AMD</keyword>
  <keyword>OCT</keyword>
  <keyword>Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

